Is RACVBP a Good Trial?

I think our job always performs better in a clinical trial than it probably does in the real world. I just don't think that Ben Kristine is in the same weight class as Polotuzumab. And we're going to see this on a couple of other abstracts and really drilling down into this metabolic tumor volume. But you know, one of my fears is that yes, metabolic tumor volume does do better than the maximum or SUV max. If anything, there is significant amount of contouring or second-guessing for nuclear medicine radiologist.